Zyomyx Closes Series 2 Preferred Financing Round of $12 Million to Enable Launch of Low-Cost, Rapid Point-of-Care CD4 Test

Novel Diagnostic Will Expand Access to HIV Treatment FREMONT, Calif., June 30, 2013 (GLOBE NEWSWIRE / Asianet-Pakistan) — Zyomyx, Inc. announced today that it completed the first closing of its Series 2 Preferred financing totaling US$12 million. The financing was led by Mylan Inc. (Nasdaq:MYL) at approximately US$6 million and included conversion of certain existing […]